Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning

被引:19
|
作者
Du, Jingcheng [1 ]
Xiang, Yang [1 ]
Sankaranarayanapillai, Madhuri [1 ]
Zhang, Meng [1 ]
Wang, Jingqi [1 ]
Si, Yuqi [1 ]
Pham, Huy Anh [1 ]
Xu, Hua [1 ]
Chen, Yong [2 ]
Tao, Cui [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
VAERS; deep learning; vaccine adverse events; named entity recognition; GUILLAIN-BARRE-SYNDROME; TEXT MINING SYSTEM; CLASSIFICATION;
D O I
10.1093/jamia/ocab014
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Automated analysis of vaccine postmarketing surveillance narrative reports is important to understand the progression of rare but severe vaccine adverse events (AEs). This study implemented and evaluated state-of-the-art deep learning algorithms for named entity recognition to extract nervous system disorder-related events from vaccine safety reports. Materials and Methods: We collected Guillain-Barre syndrome (GBS) related influenza vaccine safety reports from the Vaccine Adverse Event Reporting System (VAERS) from 1990 to 2016. VAERS reports were selected and manually annotated with major entities related to nervous system disorders, including, investigation, nervous AE, other AE, procedure, social circumstance, and temporal expression. A variety of conventional machine learning and deep learning algorithms were then evaluated for the extraction of the above entities. We further pretrained domain-specific BERT (Bidirectional Encoder Representations from Transformers) using VAERS reports (VAERS BERT) and compared its performance with existing models. Results and Conclusions: Ninety-one VAERS reports were annotated, resulting in 2512 entities. The corpus was made publicly available to promote community efforts on vaccine AEs identification. Deep learning-based methods (eg, bi-long short-term memory and BERT models) outperformed conventional machine learning-based methods (ie, conditional random fields with extensive features). The BioBERT large model achieved the highest exact match F-1 scores on nervous AE, procedure, social circumstance, and temporal expression; while VAERS BERT large models achieved the highest exact match F-1 scores on investigation and other AE. An ensemble of these 2 models achieved the highest exact match microaveraged F-1 score at 0.6802 and the second highest lenient match microaveraged F-1 score at 0.8078 among peer models.
引用
收藏
页码:1393 / 1400
页数:8
相关论文
共 50 条
  • [1] Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
    Shimabukuro, Tom T.
    Nguyen, Michael
    Martin, David
    DeStefano, Frank
    [J]. VACCINE, 2015, 33 (36) : 4398 - 4405
  • [2] Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Sever, JL
    Brenner, AI
    Gale, AD
    Lyle, JM
    Moulton, LH
    Ward, BJ
    West, DJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (12) : 825 - 840
  • [3] Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Loughlin, Anita M.
    Marchant, Colin D.
    Adams, William
    Barnett, Elizabeth
    Baxter, Roger
    Black, Steve
    Casey, Christine
    Dekker, Cornelia
    Edwards, Katherine M.
    Klein, Jerold
    Klein, Nicola P.
    LaRussah, Philip
    Sparks, Robert
    Jakob, Kathleen
    [J]. VACCINE, 2012, 30 (50) : 7253 - 7259
  • [4] Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS)
    Dayan, GH
    Iskander, J
    Glasser, J
    English-Bullard, R
    Fullerton, KE
    Chen, R
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (10) : 671 - 676
  • [5] The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety
    Iskander, JK
    Miller, ER
    Chen, RT
    [J]. PEDIATRIC ANNALS, 2004, 33 (09): : 599 - 606
  • [6] THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS)
    CHEN, RT
    RASTOGI, SC
    MULLEN, JR
    HAYES, SW
    COCHI, SL
    DONLON, JA
    WASSILAK, SG
    [J]. VACCINE, 1994, 12 (06) : 542 - 550
  • [7] Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
    Woo, Emily Jane
    Moro, Pedro L.
    Cano, Maria
    Jankosky, Christopher
    [J]. VACCINE, 2017, 35 (42) : 5618 - 5621
  • [8] Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system
    Woo, Emily Jane
    Moro, Pedro L.
    [J]. VACCINE, 2021, 39 (13) : 1812 - 1817
  • [9] Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Zhang, Bicheng
    Marquez, Paige
    Reich, Jonathan
    [J]. JOURNAL OF PEDIATRICS, 2023, 262
  • [10] Descriptive epidemiology of adverse events after immunization: Reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994
    Braun, MM
    Ellenberg, SS
    [J]. JOURNAL OF PEDIATRICS, 1997, 131 (04): : 529 - 535